Trevi Therapeutics
TRVI
#6350
Rank
NZ$1.04 B
Marketcap
$10.81
Share price
-2.73%
Change (1 day)
109.06%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -$0.51

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.55. In 2022 the company made an earnings per share (EPS) of -$1.00 an increase over its 2021 EPS that were of -$2.68.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.51-48.57%
2022-$1.00-62.67%
2021-$2.68-17.29%
2020-$3.2418.17%
2019-$2.74-46.21%
2018-$5.10